Torrent Pharmaceuticals shares declined 2.08% to Rs 4,913.50 on Thursday, July 16, 2026, during afternoon trade. The stock is part of the Nifty Next 50 index.
The company has shown consistent financial performance, with growth on both quarterly and annual bases. Its consolidated revenue has risen sharply, reflecting a strong market presence and operational efficiency.
For the quarter ending March 2026, Torrent Pharmaceuticals posted consolidated revenue of Rs 4,197 crore. This is a 41.84% increase from Rs 2,959 crore in the same quarter last year.
However, net profit for the March 2026 quarter stood at Rs 364 crore, down 26.91% from Rs 498 crore a year earlier. The earnings per share (EPS) for the quarter was Rs 11.51.
On an annual basis, revenue grew to Rs 13,979.73 crore in the year ending March 2026, up from Rs 8,508.04 crore in March 2022. That is a 64.32% rise over four years.
Net profit also rose steadily to Rs 2,138.18 crore in March 2026 from Rs 777.18 crore in March 2022, an impressive growth of 175.12%. The debt-to-equity ratio increased to 1.76 from 0.40 a year ago, indicating higher leverage.
The company's price-to-earnings (P/E) ratio for the year ending March 2026 was 66.02x, up from 57.16x in the previous year. The price-to-book (P/B) ratio also rose to 17.03x from 14.42x.
Gross profit margin stood at 31.93% in March 2026, slightly down from 32.51% a year earlier. Net profit margin was 15.29%, compared to 16.59% in March 2025.
Torrent Pharmaceuticals declared a dividend of Rs 38 per share for March 2026, higher than Rs 32 per share in March 2025. The company also announced a final dividend of Rs 9 per share (180%) on May 22, 2026, effective from May 29, 2026. This followed an interim dividend of Rs 29 per share (580%) announced on February 4, 2026, effective February 18, 2026.
Shareholders have benefited from a bonus issue in a 1:1 ratio, announced on May 25, 2022, with an ex-bonus date of July 8, 2022. A stock split was also implemented on February 20, 2006, reducing the face value from Rs 10 to Rs 5 per share.
In recent updates, Torrent Pharmaceuticals informed the exchange about general updates and an amendment to its Articles of Association (AOA) on July 8, 2026. The same day, it published a newspaper advertisement regarding a special window for transfer and dematerialization requests of physical shares.